Publications by authors named "Dejiang Tan"

Claim this Profile
O
Oncolytic Herpes Simplex Virus Therapy: Latest Advances, Core Challenges, and Future Outlook.
Yiyang Zheng, Yusheng Pei, Chunyan Dong, Jinghui Liang, Tong Cai, Dejiang Tan

Vaccines (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotoxicological Evaluation of Intrathecal Citrate Excipients: Calcium Homeostasis Disruption and Safety Implications in CNS Drug Delivery.
Jue Wang, Yuan Zhang, Qing He, Ying Du, Xia Zhang, Xinru Tan, Susu Tang, Dejiang Tan

Pharmaceutics· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines.
Junxi Wu, Jinghui Liang, Yuan Zhang, Chunyan Dong, Dejiang Tan

Int J Mol Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research and Clinical Progress of Therapeutic Tumor Vaccines.
Chunyan Dong, Zhuang Li, Dejiang Tan, Huimin Sun, Jinghui Liang

Vaccines (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-12 Delivery Strategies and Advances in Tumor Immunotherapy.
Chunyan Dong, Dejiang Tan, Huimin Sun, Zhuang Li, Linyu Zhang

Curr Issues Mol Biol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel alternative for pyrogen detection based on a transgenic cell line.
Qing He, Chuan-Fei Yu, Gang Wu, Kai-Qin Wang, Yong-Bo Ni, De-Jiang Tan

Signal Transduct Target Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized neutralization antibody analytical procedure for clinical samples based on the AQbD concept.
Jianyang Liu, Yu Bai, Mingchen Liu, Dejiang Tan, Jing Li

Signal Transduct Target Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of national standard for anti-SARS-Cov-2 neutralizing antibody in China: The first National Standard calibration traceability to the WHO International Standard.
Lidong Guan, Qunying Mao, Dejiang Tan, Jianyang Liu, Xuanxuan Zhang

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an ELISA Assay for the Determination of SARS-CoV-2 Protein Subunit Vaccine Antigen Content.
Lu Han, Chaoqiang An, Dong Liu, Zejun Wang, Lianlian Bian, Dejiang Tan

Viruses· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA cancer vaccines: Advances, trends and challenges.
Qing He, Hua Gao, Dejiang Tan, Heng Zhang, Jun-Zhi Wang

Acta Pharm Sin B· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five simple models for interfering factors test of bacterial endotoxins test.
Yusheng Pei, Tong Cai, Hua Gao, Dejiang Tan, Yuchen Zhang

Chin Med J (Engl)· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of result judgment algorithm of test for interfering factors in the bacterial endotoxins test among Chinese, Japanese, European, American, and Indian pharmacopeias.
Yusheng Pei, Tong Cai, Hua Gao, Dejiang Tan, Yuchen Zhang

Chin Med J (Engl)· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of temperature rise interpretations in the rabbit pyrogen test among Chinese, Japanese, European, and United States pharmacopeias and 2-2-2 theoretical models proposed by S. Hoffmann.
Ying Du, Xiu-Ji Li, De-Jiang Tan

Innate Immun· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis.
Lanfranco Fattorini, Renato Gennaro, Margherita Zanetti, Dejiang Tan, Lara Brunori

Peptides· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The extra cytoplasmic function sigma factor sigma(E) is essential for Mycobacterium tuberculosis virulence in mice.
Riccardo Manganelli, Lanfranco Fattorini, Dejiang Tan, Elisabetta Iona, Graziella Orefici

Infect Immun· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice.
Lanfranco Fattorini, Dejiang Tan, Elisabetta Iona, Maurizio Mattei, Federico Giannoni

Antimicrob Agents Chemother· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of the fadD33 gene in the growth of Mycobacterium tuberculosis in the liver of BALB/c mice.
Laura Rindi, Lanfranco Fattorini, Daniela Bonanni, Elisabetta Iona, Giulia Freer, Dejiang Tan

Microbiology (Reading)· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure of BALB/c mice to low doses of Mycobacterium avium increases resistance to a subsequent high-dose infection.
Lanfranco Fattorini, Roberto Nisini, Yuming Fan, Yong-Jun Li, Dejiang Tan

Microbiology (Reading)· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis